In tumor marker assays with AMAs, CEA (CA15-3, CA19-9 and CA125) and biopsies were examined following a suspicious mammogram to determine whether tumor markers aided in the diagnosis and could be used to monitor residual disease. The gene discussed is MUC16; the disease is neoplasm.